The Interaction between HCV-Infected huh7.5 Cells and HCV-Specific T Cells

C형 간염 바이러스 감염 간암 세포주와 T 림프구의 상호작용에 대한 연구

  • Kang, Hyojeung (Department of Pharmacy, College of Pharmacy, Kyungpook National University) ;
  • Cho, Hyosun (Department of Pharmacy, College of Pharmacy, Duksung Women's University)
  • 강효정 (경북대학교 약학대학 약학과) ;
  • 조효선 (덕성여자대학교 약학대학 약학과)
  • Received : 2014.03.28
  • Accepted : 2014.05.30
  • Published : 2014.06.30


Recently, Hepatitis C virus (HCV) replication system has been established using human hepatoma cells (huh cell) and a variety of HCV clones. In this study, we established an infectious HCV replication system using huh7.5 cells and J6/JFH1 clone (genotype 2a). In addition, we investigated the antigen presentation capability of HCV-infected huh7.5 cells to HCV-specific T cells. Interestingly, HCV-infected huh7.5 cells were not capable of activating HCV-specific T cells. However, huh7.5 cells stimulated by exogenous HCV peptide were able to activate HCV-specific T cells, which was shown to produce TNF-${\alpha}$ and IFN-${\gamma}$. We further examined if HCV infection has an inhibitory effect on the expression of MHC class I molecule of huh7.5 cells. We found that HCV infection did not change the expression level of MHC class I molecule on huh7.5 cells.


Supported by : 덕성여자대학교


  1. Binder, M., Kochs, G., Bartenschlager, R., and Lohmann, V. 2007. Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46, 1365-1374.
  2. Cho, H. 2011. The activation of HCV-specific CD8 T cells by HCV peptide pulsed Huh7.5 cells. Korean J. Microbiol. 47, 342-347.
  3. Juandy, J., Aichele, U., Kersting, N., Klein, R., Aichele, P., Bisse, E., Sewell, A.K., Blum, H.E., Bartenschlager, R., Lohmann, V., and et al. 2009. Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 136, 1391-1401.
  4. Keril, J.B., McKeating, A.J., and Rice, M.C. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C Virus RNA replication J. Virol. 76, 13001-13014.
  5. Kim, B.S. and Park, Y.M. 1993. Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterol. Jpn 28, (suppl5) 17S-22S.
  6. Lauer, G.M. and Walker, B.D. 2001. Hepatitis C virus infection. New Engl. J. Med. 345, 41-52.
  7. Liang, T.J., Rehermann, B., Seeff, L.B., and Hoofnagle, J.H. 2000. Pathogenesis natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132, 296-305.
  8. Nakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M.E., Kaminski, M., Gostick, E., Price, D.A., Freeman, G.J., Wherry, E.J., and Chang, K.M. 2009. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog. 5, e1000313.
  9. Nakamoto, N., Kaplan, D.E., Coleclough, J., Li, Y., Valiga, M.E., and Chang, K.M. 2008. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 134, 1927-1937.
  10. Varela-Rohena, A., Carpenito, C., Perez, E.E., Richardson, M., Parry, R.V., Milone, M., Scholler, J., Hao, X., Mexas, A., Carroll, R.G., and et al. 2008. Genetic engineering of T cells for adoptive immunotherapy. Immunol. Res. 42, 166-181.
  11. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, T., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H.G., Mizokami, M., and et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796.
  12. Yi, M. and Lemon, S.M. 2009. Genotype 1a HCV (H77S) infection system. Methods Mol. Biol. 510, 337-346.

Cited by

  1. The Applications of Hepatitis C Virus (HCV) Replication System in Developing Anti-HCV Reagents vol.45, pp.2, 2015,